Division of Thoracic and Foregut Surgery, University of Minnesota, Minneapolis, MN 55455, USA.
J Thorac Cardiovasc Surg. 2012 Mar;143(3):591-600.e1. doi: 10.1016/j.jtcvs.2011.10.088. Epub 2011 Dec 15.
We used a population-based data set to assess the association between the extent of pulmonary resection for bronchoalveolar carcinoma and survival. The reports thus far have been limited to small, institutional series.
Using the Surveillance, Epidemiology, and End Results database (1988-2007), we identified patients with bronchoalveolar carcinoma who had undergone wedge resection, segmentectomy, or lobectomy. The bronchoalveolar carcinoma histologic findings were mucinous, nonmucinous, mixed, not otherwise specified, and alveolar carcinoma. To adjust for potential confounders, we used a Cox proportional hazards regression model.
A total of 6810 patients met the inclusion criteria. Compared with the sublobar resections (wedge resections and segmentectomies), lobectomy conferred superior 5-year overall (59.5% vs 43.9%) and cancer-specific (67.1% vs 53.1%) survival (P < .0001). After adjusting for potential confounding patient and tumor characteristics, we found that patients who underwent an anatomic resection had significantly better overall (segmentectomy: hazard ratio, 0.59; 95% confidence interval, 0.43-0.81; lobectomy: hazard ratio, 0.50; 95% confidence interval, 0.44-0.57) and cancer-specific (segmentectomy: hazard ratio, 0.51; 95% confidence interval, 0.34-0.75; lobectomy: hazard ratio, 0.46; 95% confidence interval, 0.40-0.53) survival compared with patients who underwent wedge resection. Additionally, gender, race, tumor size, and degree of tumor de-differentiation were negative prognostic factors. Our results were unchanged when we limited our analysis to early-stage disease.
Using a population-based data set, we found that anatomic resections for bronchoalveolar carcinoma conferred superior overall and cancer-specific survival rates compared with wedge resection. Bronchoalveolar carcinoma's propensity for intraparenchymal spread might be the underlying biologic basis of our observation of improved survival after anatomic resection.
我们利用基于人群的数据评估了肺楔形切除术、肺段切除术和肺叶切除术治疗细支气管肺泡癌的范围与生存率之间的关系。迄今为止,这些报告仅限于小的机构系列。
利用监测、流行病学和最终结果数据库(1988-2007 年),我们确定了接受楔形切除术、肺段切除术或肺叶切除术的细支气管肺泡癌患者。细支气管肺泡癌的组织学发现包括黏液型、非黏液型、混合性、其他未特指型和肺泡癌。为了调整潜在的混杂因素,我们使用了 Cox 比例风险回归模型。
共有 6810 名患者符合纳入标准。与亚肺叶切除术(楔形切除术和肺段切除术)相比,肺叶切除术可显著提高 5 年总生存率(59.5%比 43.9%)和癌症特异性生存率(67.1%比 53.1%)(P<0.0001)。在调整了潜在的混杂患者和肿瘤特征后,我们发现接受解剖性切除术的患者总生存(肺段切除术:风险比,0.59;95%置信区间,0.43-0.81;肺叶切除术:风险比,0.50;95%置信区间,0.44-0.57)和癌症特异性生存(肺段切除术:风险比,0.51;95%置信区间,0.34-0.75;肺叶切除术:风险比,0.46;95%置信区间,0.40-0.53)明显优于接受楔形切除术的患者。此外,性别、种族、肿瘤大小和肿瘤去分化程度是预后不良的因素。当我们将分析仅限于早期疾病时,我们的结果仍然不变。
利用基于人群的数据,我们发现与楔形切除术相比,肺解剖切除术治疗细支气管肺泡癌可显著提高总生存率和癌症特异性生存率。细支气管肺泡癌的肺内播散倾向可能是我们观察到解剖性切除术后生存改善的潜在生物学基础。